News Search Results
Jan 30, 2025, 16:05 ET Azenta Announces the Election of Dipal Doshi to its Board of Directors
functions in biotechnology and pharmaceutical companies, including roles focused on business development, corporate strategy, new product planning, commercial planning and finance. Prior to joining Entrada, Mr. Doshi was the Chief Business Officer at Amicus Therapeutics, a global biotechnology company focused
More news about: Azenta
Jan 30, 2025, 09:30 ET Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill
Utah. BioUtah is comprised of manufacturers and developers of medical devices, pharmaceuticals, diagnostics and biotechnology products as well as government, academic and health care institutions all focused on improving health and wellness through the delivery of innovative
More news about: Co-Diagnostics
Jan 30, 2025, 08:20 ET Emily Whitehead Foundation Names George Eastwood Executive Director, Darshan Kulkarni Board Chair
space. Kulkarni also is a frequent speaker at industry conferences, where he shares insights into innovation, legal strategy and the future of biotechnology. Additionally, he hosts the widely followed DarshanTalks podcast focused on compliance trends, regulatory developments and the future of healthcare.
More news about: Emily Whitehead Foundation
Jan 30, 2025, 07:05 ET REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025
2025; 8:30 a.m. PT ABOUT REGENXBIO Inc.REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered
More news about: REGENXBIO Inc.
Jan 30, 2025, 06:00 ET LifeArc Ventures 2024: new investments, targeted follow-ons and substantive portfolio progress
underway in the U.S. and Europe. Kavigale (sipavibart; AZD3152), a monoclonal antibody discovered by RQ Biotechnology and licensed to AstraZeneca in 2022, received a positive CHMP opinion for prevention of COVID 19 in immunocompromised individuals. The
More news about: LifeArc
Jan 29, 2025, 16:14 ET INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
MEETING, Pa., Jan. 29, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Jan 29, 2025, 16:05 ET Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors
Jan. 29, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology,
More news about: Tyra Biosciences
Jan 29, 2025, 16:01 ET Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone
2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its subsidiary, BI Sky Global (BI), successfully completed the Human Repeated Insult Patch Test (HRIPT)
More news about: Innocan Pharma Corporation
Jan 29, 2025, 16:01 ET Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its subsidiary, BI Sky Global (BI), successfully completed the Human Repeated Insult Patch Test (HRIPT)
More news about: Innocan Pharma Corporation
Jan 29, 2025, 16:01 ET EUROPEAN COMMISSION APPROVES BLINCYTO® IN PHILADELPHIA CHROMOSOME-NEGATIVE CD19-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN THE CONSOLIDATION PHASE
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Jan 29, 2025, 14:23 ET GMGI Sequences the Genome of the Long-Lived Red Sea Urchin
to Gloucester, MA's historic waterfront, GMGI is catalyzing the regional economy. GMGI also runs the Gloucester Biotechnology Academy, a 10-month certificate training program to train recent high school graduates for careers as lab technicians. GMGI's state-of-the-art research
More news about: Gloucester Marine Genomics Institute
Jan 29, 2025, 11:33 ET REGN INVESTOR NOTICE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
e-mail at [email protected]. CASE ALLEGATIONS: Regeneron is a biotechnology company that designs products for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, among others.
More news about: Robbins Geller Rudman & Dowd LLP
Jan 29, 2025, 10:33 ET Puro Partners with Trilogene for Revolutionary Triploid Genetics in Marlborough, New Zealand
Triploid seeds represent a frontier in cannabis breeding. Unlike GMOs, triploids are developed through biotechnology techniques that combine three sets of chromosomes, enhancing their performance. This process ensures plants are non-GMO, preserving integrity while
More news about: Trilogene Seeds
Jan 29, 2025, 10:01 ET Stem Cell Factor (SCF) Market: Forecast to Grow at a 11.4% CAGR, Driven by Recombinant Innovations | Valuates Reports
proliferation and differentiation, making it essential for regenerative medicine, oncology, and hematology treatments. Continuous advancements in biotechnology and bioprocessing techniques enhance the production and quality of SCF, ensuring its availability and reliability for clinical use. The expanding
More news about: Valuates Reports
Jan 29, 2025, 09:00 ET Roche receives FDA 510(k) clearance for the first blood test in the U.S. measuring Lp(a) in molar units
Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche Diagnostics
Jan 29, 2025, 08:59 ET Kyungpook National University Researchers Discover a Novel Approach to Mapping and Engineering Enzymes for Enhanced Plastic Recycling
Kyungpook National University (KNU), led by Kyung-Jin Kim, Professor of Life Science and Biotechnology and Head of KNU Institute for Microorganisms, has come up with an innovative landscape profiling method to determine the potential of naturally
More news about: Kyungpook National University
Jan 29, 2025, 06:15 ET Epson Robots to Showcase Automation Solutions at MD&M West 2025
of experience, Epson Robots delivers robots for precision assembly and material handling applications in the aerospace, appliance, automotive, biotechnology, consumer product, electronics, food processing, medical device, pharmaceutical, plastics, semiconductor, and telecommunication industries. For
More news about: Epson America, Inc.
Jan 29, 2025, 06:00 ET Danaher Reports Fourth Quarter and Full Year 2024 Results
December 31, 2023 ($23 million pretax as reported in this line, $18 million after-tax) and technology-based intangible assets and other assets in the Biotechnology segment recorded in the three-month period and year ended December 31, 2023 ($12 million and $54 million pretax as reported in this line item, $8 million
More news about: Danaher Corporation
Jan 29, 2025, 00:00 ET Securities Class Action Filings Increase for Second Consecutive Year in 2024
number of filings in the Consumer Non-Cyclical sector increased from 54 in 2023 to 67 in 2024, largely driven by an increase in filings against Biotechnology companies in 2024 H2.While the likelihood of core filings targeting U.S. exchange-listed companies increased to 3.9% in 2024 from 3.2%
More news about: Cornerstone Research
Jan 28, 2025, 22:46 ET Amino Acid Fertilizer Market to grow by USD 392.4 Million (2025-2029), global efforts to enhance agricultural output drive growth, Report with AI impact on trends - Technavio
ensuring food security by optimizing crop quality and plant development through the provision of bioavailable nutrients. Agricultural innovation and biotechnology have led to the development of advanced amino acid fertilizers, which contribute to sustainable food systems, agroforestry, and eco-friendly agriculture.
More news about: Technavio
Jan 28, 2025, 17:31 ET Dry Eye Disease Market to Observe Stupendous Growth by 2034 | DelveInsight
Palatin Technologies, Inc., Aldeyra Therapeutics, Inc., ReGenTree, RegeneRx Biopharmaceuticals, Inc., Mimetogen, Alcon, Aerie Pharmaceuticals, BRIM Biotechnology, Inc., Seikagaku Corporation, Mitotech, Senju Pharmaceutical, Sylentis, S.A., PharmaMar, Stuart Therapeutics, VivaVision Biotech, HanAll BioPharma
More news about: DelveInsight Business Research, LLP
Jan 28, 2025, 14:30 ET THE GALIEN FOUNDATION ANNOUNCES THE MODI PRIX GALIEN INDIA 2025 AWARDS CEREMONY
Dr. Renu Swarup, former Secretary of the Department of Biotechnology, Ministry of Science & Technology, will chair the Modi Prix Galien Awards Committee. The committee comprises distinguished experts from diverse
More news about: The Galien Foundation
Jan 28, 2025, 12:45 ET SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Revance Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - RVNC
[Click here for information about joining the class action] Revance is a biotechnology company that develops, manufactures, and commercializes neuromodulators for various aesthetic and therapeutic indications in the
More news about: Pomerantz LLP
Jan 28, 2025, 12:20 ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE
Jefferies downgraded Fortrea, citing perceived weaknesses in the Company's business model as a contract research organization amid pressure on biotechnology funding. On this news, Fortrea's stock price fell $2.73 per share, or 12.29%, to close at $19.48
More news about: Pomerantz LLP
Jan 28, 2025, 10:52 ET North Park, Northwestern Launch Synthetic Biology Internship Program
North Park and Northwestern Universities are launching an internship program where North Park biotechnology majors will intern at Northwestern's Center for Synthetic Biology, working alongside world-renowned researchers in state-of-the-art facilities.
More news about: North Park University